The results from both Figure 6a,c demonstrate that even patients with no tumor TP53 mutation can have poor prognosis, but incorporation of TP53 transcript information can be used to further stratify these to identify a group of patients with very good outcomes. This evidence concerns the gene TP53 and neoplasm.